Literature DB >> 28597404

Relevance of microRNA 21 in Different Types of Hypertension.

Durairaj Sekar1, B R Shilpa2, Anupam J Das2.   

Abstract

Hypertension (HTN) is a chronic medical condition that commonly affects the aging population worldwide. The prevalence of HTN is increasing in developing countries and is one of the leading causes of death in older individuals. HTN results from a complex interplay of genetic and environmental factors. Besides, HTN can result in various other health complications such as stroke and chronic kidney diseases, if not treated. Although various studies have explained the underlying mechanisms in the pathogenesis of HTN, limited information is available on their biomarkers. MicroRNAs (miRNAs) are RNA molecules that have been recognized as key regulators for HTN. miR-21 is a common microRNA that is has been reported to be significantly upregulated in HTN individuals. Hence, miR-21 can be a potential therapeutic target for HTN. The number of studies related to miR-21 on hypertension is limited. Therefore, the main thrust of this paper is to provide an overview of the current clinical evidence and significance of miR-21 in HTN.

Entities:  

Keywords:  Biomarker; Diagnosis; Hypertension; miR-21; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28597404     DOI: 10.1007/s11906-017-0752-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  26 in total

1.  MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.

Authors:  Victoria N Parikh; Richard C Jin; Sabrina Rabello; Natali Gulbahce; Kevin White; Andrew Hale; Katherine A Cottrill; Rahamthulla S Shaik; Aaron B Waxman; Ying-Yi Zhang; Bradley A Maron; Jochen C Hartner; Yuko Fujiwara; Stuart H Orkin; Kathleen J Haley; Albert-László Barabási; Joseph Loscalzo; Stephen Y Chan
Journal:  Circulation       Date:  2012-02-27       Impact factor: 29.690

Review 2.  Epidemiology and Genetics of Hypertension.

Authors:  Taposh Sarkar; Narinder Pal Singh
Journal:  J Assoc Physicians India       Date:  2015-09

3.  miR-21 and miR-214 are consistently modulated during renal injury in rodent models.

Authors:  Laura Denby; Vasudev Ramdas; Martin W McBride; Joe Wang; Hollie Robinson; John McClure; Wendy Crawford; Ruifang Lu; Dianne Z Hillyard; Raya Khanin; Reuven Agami; Anna F Dominiczak; Claire C Sharpe; Andrew H Baker
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

Review 4.  Clinical Significance of Endothelial Dysfunction in Essential Hypertension.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Areti Triantafyllou; Stella Douma
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

5.  MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial Translation.

Authors:  Huaping Li; Xiaorong Zhang; Feng Wang; Ling Zhou; Zhongwei Yin; Jiahui Fan; Xiang Nie; Peihua Wang; Xiang-Dong Fu; Chen Chen; Dao Wen Wang
Journal:  Circulation       Date:  2016-08-19       Impact factor: 29.690

6.  MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.

Authors:  Sachindra Raj Joshi; Vidhi Dhagia; Salina Gairhe; John G Edwards; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-15       Impact factor: 4.733

Review 7.  Recent Advances in the Genetics of Hypertension.

Authors:  Loo Keat Wei; Anthony Au; Lai Kuan Teh; Huey Shi Lye
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 8.  Role of microRNA 21 in diabetes and associated/related diseases.

Authors:  Durairaj Sekar; Basam Venugopal; Punitha Sekar; Krishnan Ramalingam
Journal:  Gene       Date:  2016-01-27       Impact factor: 3.688

9.  Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension.

Authors:  Mahir Cengiz; Omer Faruk Karatas; Erkan Koparir; Serap Yavuzer; Chayar Ali; Hakan Yavuzer; Emre Kirat; Yesari Karter; Mustafa Ozen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

10.  miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.

Authors:  Lucio Iannone; Lan Zhao; Olivier Dubois; Lucie Duluc; Christopher J Rhodes; John Wharton; Martin R Wilkins; James Leiper; Beata Wojciak-Stothard
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

View more
  12 in total

Review 1.  Noncoding RNAs in the Regulatory Network of Hypertension.

Authors:  Gengze Wu; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

2.  Comment on the potential role of microRNAs in hypertension.

Authors:  Durairaj Sekar
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

Review 3.  Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs.

Authors:  Ji-Ru Zhang; Hai-Jian Sun
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-22       Impact factor: 3.727

4.  Circular RNA: a new biomarker for different types of hypertension.

Authors:  Durairaj Sekar
Journal:  Hypertens Res       Date:  2019-07-17       Impact factor: 3.872

5.  Differential expression of MicroRNA let-7e and 296-5p in plasma of Egyptian patients with essential hypertension.

Authors:  Heba K Badawy; Dina M Abo-Elmatty; Noha M Mesbah
Journal:  Heliyon       Date:  2018-11-24

6.  Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.

Authors:  Xiaolan Zheng; Yi Zhang; Peng Yue; Lei Liu; Chuan Wang; Kaiyu Zhou; Yimin Hua; Gang Wu; Yifei Li
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

Review 7.  Noncoding RNAs in Hypertension.

Authors:  Amela Jusic; Yvan Devaux
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

Review 8.  Epigenetic Biomarkers in Cardiovascular Diseases.

Authors:  Carolina Soler-Botija; Carolina Gálvez-Montón; Antoni Bayés-Genís
Journal:  Front Genet       Date:  2019-10-09       Impact factor: 4.599

9.  Inhibition of EGFR Signaling Protects from Mucormycosis.

Authors:  Tonya N Watkins; Teclegiorgis Gebremariam; Marc Swidergall; Amol C Shetty; Karen T Graf; Abdullah Alqarihi; Sondus Alkhazraji; Abrar I Alsaadi; Vonetta L Edwards; Scott G Filler; Ashraf S Ibrahim; Vincent M Bruno
Journal:  MBio       Date:  2018-08-14       Impact factor: 7.867

10.  Circulating miRNA-21 as a diagnostic biomarker in elderly patients with type 2 cardiorenal syndrome.

Authors:  Yi Liang; WenJun Zhao; Yan Wang; GuangPing Fu; QingQuan Li; XuChen Min; YiFang Guo
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.